US11826457B2ActiveUtilityA1
Redness correcting skin care formulations
Est. expiryJun 12, 2034(~7.9 yrs left)· nominal 20-yr term from priority
A61K 8/9789A61K 8/19A61K 8/27A61K 8/29A61K 8/34A61K 8/368A61K 8/416A61K 8/498A61K 8/4926A61K 8/55A61K 8/602A61K 8/733A61K 8/891A61K 8/9711A61K 8/9717A61K 8/9722A61K 8/9728A61Q 17/04A61Q 19/00A61Q 19/007A61Q 19/02A61Q 19/08A61K 2800/30A61K 2800/43A61K 2800/72
73
PatentIndex Score
0
Cited by
13
References
6
Claims
Abstract
In some embodiments, soothing redness correction formulations are provided. In other embodiments, formulations to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation. In yet other embodiments, certain formulations are renewal formulations adapted to treat the eye area to, for example, reduce laxity, puffiness, wrinkles and/or dark circles around the eye.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A formulation for treating skin irritation comprising effective amounts of:
(i) a first skin conditioning agent,
wherein said first skin conditioning agent comprises a Zingiber officinale extract;
(ii) a second skin conditioning agent,
wherein said second skin conditioning agent comprises at least one of Asteraceae extract or bisabolol, wherein said Asteraceae extract and bisabolol are synthetic or plant extracts;
(iii) a third skin conditioning agent,
wherein the third skin conditioning agent comprises a Crithmum maritimum extract,
(iv) a fourth skin conditioning agent,
wherein the fourth skin conditioning agent additionally functions as an antimicrobial,
(v) an anti-inflammatory agent,
wherein the formulation is a topical formulation suitable for topical delivery and treating skin irritation, and
(vi) one or more synthetic antimicrobial preservatives selected from phenoxyethanol, ethylhexylglycerin, benzoic acid, sodium benzoate, and dehydroacetic acid.
2. The formulation of claim 1 ,
wherein the second skin conditioning agent comprises an Asteraceae extract and at least one of the Zingiber officinale and Asteraceae extracts comprise root extracts; and
wherein the fourth skin conditioning agent comprises a Magnolia officinalis extract, optionally a Magnolia officinalis root extract.
3. The formulation of claim 1 , further comprising a sun protection agent,
wherein said sun protection agent comprises zinc oxide and titanium dioxide, and
wherein said sun protection agent offers a sun protection factor of SPF 30 or more.
4. The formulation of claim 1 ,
wherein the first skin conditioning agent is provided in a range of 0.005-5%
wherein the second skin conditioning agent is provided in a range of 0.05-5%;
wherein the third skin conditioning agent is provided in a range of 0.02-5%;
wherein the fourth skin conditioning agent is provided in a range of 0.001-5%;
wherein the ranges are provided as % m/m, % w/w, % w/v, % m/v, or % v/v of the formulation.
5. The formulation of claim 1 ,
wherein the first skin conditioning agent is provided in a range of 0.005-5%
wherein the second skin conditioning agent is provided in a range of 0.05-5%;
wherein the third skin conditioning agent is provided in a range of 0.02-5%;
wherein the fourth skin conditioning agent is provided in a range of 0.001-5%;
wherein the anti-inflammatory agent is provided in a range of 0.05-5%;
wherein the anti-inflammatory agent comprises a Vitamin E compound;
wherein the ranges are provided as % m/m, % w/w, % w/v, % m/v, or % v/v of the formulation; and
wherein the formulation is a paraben-free formulation.
6. The formulation of claim 1 , wherein the formulation is rated at Protection Grade of Ultraviolet A (PA) of 16 or greater in a Persistent Pigment Darkening (PPD) test.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.